Gainers
- Helius Medical Tech (NASDAQ:HSDT) stock rose 47.8% to $1.11 during Tuesday's pre-market session. The market value of their outstanding shares is at $4.1 million.
- Dogwood Therapeutics (NASDAQ:DWTX) shares increased by 36.89% to $2.56. The market value of their outstanding shares is at $3.4 million.
- TNF Pharmaceuticals (NASDAQ:TNFA) shares rose 19.82% to $1.39. The market value of their outstanding shares is at $3.8 million.
- Redhill Biopharma (NASDAQ:RDHL) stock increased by 19.75% to $6.75. The company's market cap stands at $8.6 million.
- Tempus AI (NASDAQ:TEM) shares rose 19.14% to $41.88. The company's market cap stands at $6.5 billion.
- Design Therapeutics (NASDAQ:DSGN) stock rose 17.39% to $5.94. The company's market cap stands at $336.3 million.
Losers
- Baird Medical Investment (NASDAQ:BDMD) shares declined by 14.1% to $7.6 during Tuesday's pre-market session. The market value of their outstanding shares is at $276.3 million.
- AEON Biopharma (AMEX:AEON) shares fell 12.47% to $0.13. The market value of their outstanding shares is at $10.7 million.
- Biomerica (NASDAQ:BMRA) stock decreased by 10.94% to $0.57. The company's market cap stands at $10.4 million.
- Akoya Biosciences (NASDAQ:AKYA) stock fell 10.64% to $2.52. The market value of their outstanding shares is at $124.9 million.
- Rapid Micro Biosystems (NASDAQ:RPID) shares fell 9.76% to $1.11. The company's market cap stands at $47.7 million.
- Bio-Rad Laboratories (NYSE:BIO) stock decreased by 9.1% to $310.0. The company's market cap stands at $8.8 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BDMDBaird Medical Investment Holdings Ltd
$1.160.87%
BIOBio-Rad Laboratories Inc
$313.53-%
BMRABiomerica Inc
$2.52-1.95%
DSGNDesign Therapeutics Inc
$9.28-%
DWTXDogwood Therapeutics Inc
$2.78-0.06%
HSDTSolana Co
$3.310.30%
RDHLRedhill Biopharma Ltd
$1.36-%
RPIDRapid Micro Biosystems Inc
$4.210.72%
TEMTempus AI Inc
$70.440.15%
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

